The rational design of a pH-tunable DNA tetrahedron (pHTd) is reported through the strategic incorporation of an i-motif, enabling assembly at physiological pH and disassembly under acidic conditions, thereby exhibiting reversible structural transitions in response to pH changes.
Abstract
The development of stimuli-responsive nanocarriers has emerged as a promising strategy for improving the precision and efficacy of drug delivery systems. Among these, DNA nanostructures offer unique advantages owing to their inherent programmability, biocompatibility, and precise structural tunability. Although three-dimensional DNA nanostructures, such as DNA tetrahedrons, have been reported to undergo pH-driven disassembly for applications in drug delivery and cargo protein release, their structural design permits only partial disassembly and impedes reversible regulation, thereby limiting their broader applications. Here, we report the rational design of a pH-tunable DNA tetrahedron (pHTd) through the strategic incorporation of an i-motif, enabling assembly at physiological pH and disassembly under acidic conditions, thereby exhibiting reversible structural transitions in response to pH changes. The pHTd displayed promising serum stability with negligible cytotoxicity. Furthermore, pHTd loaded with the anticancer drug Doxorubicin (Dox) exhibited enhanced cytotoxicity compared with free Dox, accompanied by efficient cellular uptake, highlighting its potential as a smart drug delivery platform. In addition, we demonstrate DNA nanostructures including a tetrahedron (pHTd-2), a triangle (pHT), and a square (pHS) that exhibit contrasting pH-responsive behaviors, collectively representing a Janus-like system with opposite structural responses to a common pH stimulus. Collectively, this work establishes a general framework for engineering reversible pH-responsive DNA nanostructures and broadens their potential applications in targeted drug delivery, bioimaging, and logic-gated nanodevices.
The present study emphasises niosomes as versatile nanocarriers with great potential for the next generation of drug delivery and describes the major challenges that need to be overcome for further clinical and commercial translation.
Khashayar Khodaverdi, S. M. Naghib, Ghasem Takdehghan et al.· BioNanoScience· 0 citations
This review highlights recent progress in the design and application of stimuli-responsive MSNs for cancer therapy, with particular emphasis on mechanisms of intracellular uptake, factors influencing cellular internalization, and strategies for controlled drug release.
U. Abbasi, Md. Saifuddin, Mahak Fatima et al.· Journal of drug targeting (P...· 0 citations
The development of biocompatible sodium bis(2-ethylhexyl) sulfosuccinate (AOT)-based nanovesicles for the co-delivery of hydrophilic and hydrophobic anti-cancer agents, doxorubicin and curcumin are reported.
Covalent organic frameworks (COFs) are an emerging class of porous organic polymers with a broad spectrum of possible applications because of their large void spaces and modular pores. Despite excellent cytocompatibility, porosity, and biodegradability of COFs, their practical implementations in nanomedicine have been...
Sukanya Bhunia, Kaivalya A. Deo, Manish K. Jaiswal· ChemMedChem· 0 citations
This review examines the main classes of nanoplatforms currently explored for cancer therapy, including inorganic, polymeric, lipid-based, and hybrid organic–inorganic systems, and considers emerging directions in AI-guided nanoparticle engineerization design and natural-compound-based nanomedicines, both of which are...
C. Boncristiani, F. Baldassarre, Khadija Eddahaoui et al.· Materials· 0 citations
Over the last few decades, carbon-based nanomaterials have attracted significant attention owing to their high surface area-to-volume ratio, tunable surface properties, greater physicochemical stability, and ease of multi-functionalization. This review comprehensively summarizes the role of carbon-based nanomaterials,...
Ipsita Som, Saheli Roy, Mukta Gan Choudhuri et al.· Journal of materials chemist...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.